Nalaganje...
Drug resistance mechanisms in Japanese anaplastic lymphoma kinase‐positive non–small cell lung cancer and the clinical responses based on the resistant mechanisms
The treatment for anaplastic lymphoma kinase (ALK)‐positive lung cancer has been rapidly evolving since the introduction of several ALK tyrosine kinase inhibitors (ALK‐TKI) in clinical practice. However, the acquired resistance to these drugs has become an important issue. In this study, we collecte...
Shranjeno v:
| izdano v: | Cancer Sci |
|---|---|
| Main Authors: | , , , , , , , , , , , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
John Wiley and Sons Inc.
2020
|
| Teme: | |
| Online dostop: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7060465/ https://ncbi.nlm.nih.gov/pubmed/31961053 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/cas.14314 |
| Oznake: |
Označite
Brez oznak, prvi označite!
|